| DLBCL | Diffuse large B-cell lymphoma |
| GEP | Gene expression profiling |
| COO | Cell of origin |
| GCB | Germinal-center B-cell–like subgroup |
| ABC | Activated B cell–like subtype |
| R | Rituximab |
| CHOP | Cyclophosphamide, doxorubicin, vincristine, and prednisone |
| EFS | Event-free survival |
| OS | Overall survival |
| FCM | Flow cytometry |
| FSC | Forward scatter |
| SSC | Side scatter |
| NF-kB | Nuclear factor kB |
| ERK | Extracellular signal-regulated kinases |
| IC50 | Inhibitory concentration 50 |
| INPP5D | Src homology 2 domain containing inositol polyphosphate 5-phosphatase 1 |
| IHC | Immunohistochemistry |
| PCR | Polymerase chain reaction |
| PTPN6 | Protein Tyrosine Phosphatase Non-Receptor Type 6 |
| SAM | Significance analysis of microarray |
| STR | Short tandem repeat |
| SYK | Spleen tyrosine kinase |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.